Decoy Therapeutics Inc. Stock Split Ratio
Decoy Therapeutics Inc. (DCOY) had Stock Split Ratio of 6.67% as of 2025-08-15, per its 10-Q filed 2025-11-14.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2025-11-14
- 2025-08-15: Stockholders' Equity Note, Stock Split, Conversion Ratio 6.67%.
- 2024-06-14: Stockholders' Equity Note, Stock Split, Conversion Ratio 12.50%.
- 2022-10-14: Stockholders' Equity Note, Stock Split, Conversion Ratio 4.00%.
- 2015-01-31: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 23.35%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month |
|---|---|---|
| 2025-08-15 | 6.67% 10-Q · filed 2025-11-14 | |
| 2024-06-14 | 12.50% 10-Q · filed 2025-11-14 | |
| 2022-10-14 | 4.00% 10-K · filed 2025-03-21 | |
| 2015-01-31 | 23.35% 10-K · filed 2018-03-07 | |
| 2015-01-15 | 23.35% 10-Q · filed 2015-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |